StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Zhengye Biotechnology's total debt was CN¥65.80M at Dec 31, 2025. For fiscal 2025 it was CN¥65.80M, down 23.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥65.80M-23.9%
FY2024Dec 31, 2024CN¥86.43M-3.8%
FY2023Dec 31, 2023CN¥89.85M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥65.80M–
Q2 FY2025Jun 30, 2025CN¥81.06M–
Q4 FY2024Dec 31, 2024CN¥86.43M–
Q4 FY2023Dec 31, 2023CN¥89.85M–

More Zhengye Biotechnology figures

See a number that looks wrong?